Ludwig Maximilian University of Munich

Alzheimer's disease & dementia

Identification of a central regulator

A new study by LMU researchers shows that the protein ApoE plays a key role in the pathogenesis of diseases associated with chronic inflammation, and identifies a new target for therapeutic strategies against atherosclerosis ...

Immunology

How cytoplasmic DNA triggers inflammation in human cells

A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...

Neuroscience

The rhythm of fear mapped in neuronal networks

Researchers based in Munich and Bordeaux have detected coordinated oscillations in the activities of neuronal networks in two distinct areas of the brain, which are characteristic for a specific fear response.

Neuroscience

Grid cells: Reading the neural code for space

The cognitive map for spatial navigation is thought to rely on grid cells. Scientists at Ludwigs-Maximilians-Universitaet in Munich and Harvard University have now put forward a mathematical theory that explains key grid-cell ...

Diseases, Conditions, Syndromes

MERS virus: Drying out the reservoir

A German-Dutch team has succeeded in immunizing dromedaries against the MERS virus. As the camels appear to be the major reservoir of the virus, the vaccine should also reduce the risk of future outbreaks of the disease in ...

Immunology

New immunoregulation and biomarker

Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus ...

Neuroscience

Virtual motion, real consequences

Ludwig Maximilian University of Munich researchers have shown that virtual optical stimuli can lead to aftereffects that significantly alter our perception of self-motion. This finding has implications for safe use of emerging ...

Medical research

Photopharmacology: Optical control of insulin secretion

Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have chemically modified an anti-diabetic agent so as to make its action dependent on light. The resulting prototype compound, termed JB253, induces release of ...

page 6 from 24